Journals / Acıbadem Üniversitesi Sağlık Bilimleri Dergisi / 2018 / Sayı: 4

Diagnostic Role of Scd14-Subtype As a Sepsis Biomarker In Febrile Neutropenic Pediatric Oncology Patients

ATEŞLI NÖTROPENIK PEDIATRIK ONKOLOJI HASTALARINDA SCD14 ALT TIPININ SEPSIS BIYOBELIRTECI OLARAK TANIDAKI ROLÜ

Pages
395–400
Publication Date
2018-12-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: Biomarkers failed to display a discriminative value between bacteremia/sepsis and fever without origin groups, whereas presepsin was found to be an indicator of the presence of bacterial growth in hemoculture and was shown to have a potential diagnostic value.Conclusion: Presepsin might be used as an additional diagnostic tool for the detection of bacteremia/sepsis in childhood FN patients

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction and Objective: Febrile neutropenia FN is one of the most common complications of cancer chemotherapy and requires urgent treatment.
📊
Key Findings & Data:Methods: Twenty-four pediatric patients, with a total 29 febrile neutropenic episodes were enrolled in this study.
💡
Conclusion & Impact:Results: Biomarkers failed to display a discriminative value between bacteremia/sepsis and fever without origin groups, whereas presepsin was found to be an indicator of the presence of bacterial growth in hemoculture and was shown to have a potential diagnostic value.Conclusion: Presepsin might be used as an additional diagnostic tool for the detection of bacteremia/sepsis in childhood FN patients
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Biomarker · Febrile Neutropenia · Presepsin

Abstract

Introduction and Objective: Febrile neutropenia FN is one of the most common complications of cancer chemotherapy and requires urgent treatment. Upon diagnosis of childhood FN, culture samples should be obtained and a broad spectrum antibiotherapy should be administered immediately. However, bacterial infections are not the only cause of fever in neutropenic pediatric patients; chemotherapeutics, the disease itself, as well as viral and fungal agents can also be the cause of fever. Various biomarkers have been studied to differentiate the cause of fever to date. Infections are mostly lethal in neutropenic patients, early stage differential biomarkers are, therefore, of utmost importance. It is the aim of this study to assess the potential of presepsin as an additional diagnostic tool for the detection of bacteremia/sepsis in childhood Febrile Neutropenia FN patients. Methods: Twenty-four pediatric patients, with a total 29 febrile neutropenic episodes were enrolled in this study. One patient with 3 FN episodes, three patients with 2 FN episodes were admitted to our clinic during the study. Patients were classified into bacteremia/sepsis and fever without origin groups. Serum samples were collected after confirmation of FN and analyzed for presepsin, c-reactive protein CRP and procalcitonin PCT according to instructions of manufacturers. Results: Biomarkers failed to display a discriminative value between bacteremia/sepsis and fever without origin groups, whereas presepsin was found to be an indicator of the presence of bacterial growth in hemoculture and was shown to have a potential diagnostic value.Conclusion: Presepsin might be used as an additional diagnostic tool for the detection of bacteremia/sepsis in childhood FN patients

Özet

Giriş ve Amaç: Bu çalışmada, Çocukluk çağında gelişen Febril Nötropeni FN hastalarında presepsin’in bakteriyemi/sepsisin saptanmasında ek bir tanı aracı olarak potansiyelini değerlendirmek amaçlanmıştır. Febril nötropeni kanser kemoterapisinin en yaygın komplikasyonlarından biridir ve acilen bir tedavi gerektirir. FN’ de kültür örnekleri alınmalı ve hızlı bir şekilde geniş spektrumlu antibiyoterapi uygulanmalıdır. Nötropenik hastalarda ateşin tek nedeni bakteriyel enfeksiyon değildir. Kemoterapötikler, hastalığın kendisi, viral ve fungal ajanlar ateşin diğer sebepleri olabilir. Ateş nedenini ayırt etmek için çeşitli biyolojik belirteçler araştırılmaktadır. Enfeksiyonlar nötropenik hastalarda çoğunlukla öldürücüdür, bu nedenle erken evredeki farklı biyobelirteçler bulunması son derece önemlidir.Yöntem: Toplam 29 febril nötropenik atak ve 24 pediatrik hasta çalışmaya alındı. Hastalar, bakteriemi/sepsis ve odağı olmayan ateş grubu olarak sınıflandırıldı. Serum örnekleri, FN teşhisi sonrasında toplandı ve presepsin, c-reaktif protein CRP ve prokalsitonin PCT konsantrasyonları analiz edildi.Bulgular: Bilinen biyolojik belirteçler, bakteriemi/sepsis ile odağı olmayan ateş grubu arasında ayırt edici bir değer göstermezken, presepin, hemokültürde bakteri gelişiminin bir göstergesi olarak anlamlı bulundu ve potansiyel bir tanısal değeri olduğu gösterildi.Sonuç: Presepsin, çocukluk çağı FN’li hastalarda bakteriyemi/sepsis tespiti için ilave bir tanı aracı olarak kullanılabilir

🔖

Cite This Article

KUTER, Ş., CANPOLAT, C., YILANCIOĞLU, K. (2018). Diagnostic Role of Scd14-Subtype As a Sepsis Biomarker In Febrile Neutropenic Pediatric Oncology Patients. Acıbadem Üniversitesi Sağlık Bilimleri Dergisi, Sayı: 4, 395–400. https://ajindex.com/articles/162838

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Fioredda F, Calvillo M, Bonanomi S, Coliva T, Tucci F, Farruggia P, et al. Congenital and acquired neutropenias consensus guidelines on therapy and follow-up in childhood from the Neutropenia Committee of the Marrow Failure Syndrome Group of the AIEOP (Associazione Italiana Emato-Oncologia Pediatrica). Am J Hematol 2012
  2. [CrossRef] 2. Miedema KG, de Bont ES, Elferink RF, van Vliet MJ, Nijhuis CS, Kamps WA, et al. The diagnostic value of CRP, IL-8, PCT, and sTREM-1 in the detection of bacterial infections in pediatric oncology patients with febrile neutropenia. Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer 2011
  3. [CrossRef] 3. Samraj RS, Zingarelli B, Wong HR. Role of biomarkers in sepsis care. Shock 2013
  4. [CrossRef] 4. Karzai W, Oberhoffer M, Meier-Hellmann A, Reinhart K. Procalcitonin- -a new indicator of the systemic response to severe infections. Infection 1997
  5. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001
  6. [CrossRef] 6. Bozza FA, Bozza PT, Castro Faria Neto HC. Beyond sepsis pathophysiology with cytokines: what is their value as biomarkers for disease severity? Mem Inst Oswaldo Cruz 2005
  7. 100 Suppl 1: 217-21. [CrossRef] 7. Henriquez-Camacho C, Losa J. Biomarkers for sepsis. Biomed Res Int 2014
  8. 547818. [CrossRef] 8. Secmeer G, Devrim I, Kara A, Ceyhan M, Cengiz B, Kutluk T, et al. Role of procalcitonin and CRP in differentiating a stable from a deteriorating clinical course in pediatric febrile neutropenia. Journal of pediatric hematology/oncology 2007
  9. [CrossRef] 9. Urbonas V, Eidukaite A, Tamuliene I. The predictive value of soluble biomarkers (CD14 subtype, interleukin-2 receptor, human leucocyte antigen-G) and procalcitonin in the detection of bacteremia and sepsis in pediatric oncology patients with chemotherapy-induced febrile neutropenia. Cytokine 2013
  10. [CrossRef] 10. Parnaby RM, Eaton SE, Shafi MS, Bell D. The value of serum C-reactive protein levels as a marker of sepsis in intensive care unit patients. Clinical intensive care: international journal of critical & coronary care medicine 1994
  11. Shozushima T, Takahashi G, Matsumoto N, Kojika M, Okamura Y, Endo S. Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of s